A real-world study of alemtuzumab in a cohort of Italian patients.
Eur J Neurol
; 29(1): 257-266, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34558755
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Eur J Neurol
Journal subject:
NEUROLOGIA
Year:
2022
Type:
Article
Affiliation country:
Italy